also on other fortune lists

company facts

g500 stats

Global 500

Jeff Roberson — AP/REX/Shutterstock





Centene is a bit of an outlier among its health insurance peers. While the past few years have produced a cascade of insurer exits from Obamacare’s marketplaces — particularly amid uncertainty about the health law’s future and the Trump administration’s thousand cuts to the program — Centene has doubled down. And it’s paid off in spades. More than 1.4 million Americans signed up for Centene’s federal Affordable Care Act plans during the most recent open enrollment season, leading CEO Michael Neidorff to exclaim the firm “had planned on incremental growth, but not that much.” The company also has a growing footprint in the managed care market fueled by deals such as its $3.75 billion acquisition of Fidelis Care last fall.

Looking for leads, investment insights, or competitive intelligence?


Michael F. Neidorff


Health Care


Health Care: Insurance and Managed Care

HQ Location

St. Louis

Years on Global 500 List




Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$48,57219.3%
Profits ($M)$828.047.3%
Assets ($M)$21,855
Total Stockholder Equity ($M)$6,850
Profit Ratios
Profit as % of Revenues1.7%
Profits as % of Assets3.8%
Profits as % of Stockholder Equity12.1%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Centene

Health Care Stocks Down After Federal Judge Rules Affordable Care Act Is Unconstitutional

The court decision is expected to be appealed and won't affect 2019 health care plans.

Read More →
Three Years After Michael Brown's Death Ferguson Has New Leadership, Contentious Debates And Hope

A current of activism and community building still runs strong in the St. Louis suburb.

Read More →
This Health Insurer Shows You Can Make Money With Obamacare After All

Centene boosted profits in 2Q and raised its outlook for the full year

Read More →